1. Cancer Science Institute of Singapore, National University of Singapore, Singapore;
2. Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan;
3. Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan;
4. Laboratory of DNA Information Analysis, and
5. Laboratory of Sequence Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan;
6. Munich Leukemia Laboratory, Munich, Germany;
7. Department of Hematology, Nippon Medical School, Tokyo, Japan;
8. Department of Paediatrics, National University Health System, Singapore;
9. Department of Advanced Diagnosis, Clinical Research Center, Nagoya Medical Center, Nagoya, Japan;
10. Department I of Internal Medicine, University of Cologne, Cologne, Germany;
11. Department of Leukemia, MD Anderson Cancer Center, Houston, TX;
12. Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX;
13. Cedars-Sinai Medical Center, Division of Hematology/Oncology, University of California Los Angeles, School of Medicine, Los Angeles, CA;
14. Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Taipei, Taiwan;
15. Department of Hematology, Oncology and Tumorimmunology, Charite University School of Medicine, Berlin, Germany; and
16. National University Cancer Institute, National University Hospital, Singapore